Yahoo Suche Web Suche

Suchergebnisse

  1. Suchergebnisse:
  1. Paul E. Sax, MD Contributing Editor NEJM Journal Watch Infectious Diseases . Biography | Disclosures | Summaries. Learn more about HIV and ID Observations.

  2. Paul Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School. A past Editor-in-Chief of NEJM Journal Watch HIV/AIDS, he left that position in 2014 to assume that role for Open Forum Infectious Diseases.

  3. 26. Juli 2023 · REPRIEVE: Significant decrease in major adverse cardiovascular events with pitavastin. RCT trial enrolled only low-to-moderate CV risk PWH, for whom a statin might not otherwise be prescribed. Important clinical trial with direct relevance to pt care. https://t.co/dVtQgtAGhz. — Paul Sax (@PaulSaxMD) July 24, 2023.

  4. Awards. Boston Magazine Top Doctor, 2022. Castle Connolly America's Top Doctors, 2022. Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital (BWH), where he holds the Bruce and Robert Beal Distinguished Chair, and Professor of Medicine at Harvard Medical School. Dr.

  5. Paul Edward Sax. Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School. Verified email at bwh.harvard.edu. HIV AIDS Infectious Diseases. Title. Sort. Sort by citations Sort by year Sort by title. Cited by.

  6. Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital and Professor of Medicine at Harvard Medical School. He holds the Bruce A. Beal and Robert L. Beal Distinguished Chair in Infectious Diseases. Dr. Sax received his MD from Harvard Medical School, did his residency in Internal Medicine at ...

  7. 31. Juli 2023 · It's notable that major advances in HIV research have drifted away from an ID doctor's typical areas of focus, says Dr. Paul Sax. In the latest HIV and ID Observations, he demonstrates how the results of REPRIEVE — a study of statins for people with HIV — highlight the shift in HIV care from ID to general medicine.